RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
86 hedge funds and large institutions have $727M invested in Revance Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less call options, than puts
Call options by funds: $776K | Put options by funds: $909K
Holders
86
Holding in Top 10
1
Calls
$776K
Puts
$909K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$9.99M | |
| 3 | +$6.91M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$4.4M |
| 5 |
PC
PointState Capital
New York
|
+$4.27M |
Top Sellers
| 1 | -$9.74M | |
| 2 | -$8.93M | |
| 3 | -$4.01M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.26M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$735K |